October 16, 2021 Comments Off on New patent for Esperion Theraps drug NEXLIZET Posted in: Patent Added Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are six patents protecting this drug. NEXLIZET drug…
The post New patent for Esperion Theraps drug NEXLIZET appeared first…
October 16, 2021 Comments Off on New patent for Am Regent drug INJECTAFER Posted in: Patent Added Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Am Regent drug INJECTAFER appeared first on DrugPate…
